Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
31.87
+1.22 (3.98%)
Sep 22, 2026, 2:32 PM EDT - Market open
Caris Life Sciences Employees
Caris Life Sciences had 1,846 employees as of December 31, 2025. The number of employees increased by 77 or 4.35% compared to the previous year.
Employees
1,846
Change
77
Growth
4.35%
Revenue / Employee
$536,081
Profits / Employee
$56,953
Market Cap
9.01B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,846 | 77 | 4.35% | 1,846 | 0 |
| Dec 31, 2024 | 1,769 | 1 | 0.06% | 1,769 | 0 |
| Dec 31, 2023 | 1,768 | - | - | 1,762 | 6 |
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,480 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Vaxcyte | 507 |
| TG Therapeutics | 399 |
| Immunovant | 315 |
| Praxis Precision Medicines | 168 |
CAI News
- 13 days ago - Caris Life Sciences initiated with a Neutral at UBS - TheFly
- 20 days ago - Caris Life Sciences to present new research at IASCL 2026 - TheFly
- 6 weeks ago - Caris Life Sciences price target raised to $33 from $32 at BTIG - TheFly
- 6 weeks ago - Caris Life Sciences price target raised to $26 from $25 at Evercore ISI - TheFly
- 6 weeks ago - Caris Life Sciences reports Q2 EPS 0c, consensus 1c - TheFly
- 6 weeks ago - Caris Life Sciences sees 2026 revenue $1.03B-$1.04B, consensus $”This was a reco - TheFly
- 6 weeks ago - Caris Life Sciences Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Caris Life Sciences Earnings release: Q2 2026 - Filings